Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Fei WuMatthew R SmithAriel L MuellerSeth A KlapmanLucinda L EverettTimothy HouleBraden KuoIon A HobaiPublished in: Canadian journal of anaesthesia = Journal canadien d'anesthesie (2024)
In fasting patients, GLP-1 agonist therapy was associated with an increased incidence of residual gastric contents, potentially posing an additional risk of periprocedural pulmonary aspiration.
Keyphrases
- patients undergoing
- end stage renal disease
- blood glucose
- ejection fraction
- newly diagnosed
- healthcare
- insulin resistance
- pulmonary hypertension
- palliative care
- prognostic factors
- percutaneous coronary intervention
- risk factors
- peritoneal dialysis
- type diabetes
- stem cells
- quality improvement
- mesenchymal stem cells
- blood pressure
- metabolic syndrome
- ultrasound guided
- patient reported outcomes
- pain management
- bone marrow
- coronary artery disease
- small bowel
- smoking cessation